Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 16Unknown 5Not yet recruiting 4Completed 3Active not recruiting 3Terminated 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Sarcoma 1Head & Neck 1Gastrointestinal 1Dermatologic 1

Conditions

Thyroid Neoplasms 1Sarcoma 1Papillary Thyroid Microcarcinoma 1Neoplasm Metastasis 1Melanoma 1Liver Neoplasms 1Carcinoma 1

Interventions

Cyclophosphamide 1495Cisplatin 1431Paclitaxel 1339Radiotherapy 1308Carboplatin 1264Gemcitabine 1225Docetaxel 1134Bevacizumab 1068Fluorouracil 906Doxorubicin 799Dexamethasone 753Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 693Etoposide 674Irinotecan 639Filgrastim 624Nivolumab 585Cytarabine 585Leucovorin 582Vincristine 512Cetuximab 478Prednisone 477Bortezomib 472Trastuzumab 469Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 443Lenalidomide 434

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Transurethral Resection of Prostate × Clear all
NCT03993678 2025-12-30

Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors.

Swiss Cancer Institute

Phase 1/2 Completed
28 enrolled
DermatologicSarcoma

Melanoma, Sarcoma

NCT06583057 2024-09-03

Multicenter Comparison of Thermal Ablation Versus Thyroid Lobectomy for Subcapsular Papillary Thyroid Microcarcinoma

Chinese PLA General Hospital

Completed
2,000 enrolled
Head & Neck

Papillary Thyroid Microcarcinoma, Thyroid Neoplasms

NCT05495529 2022-08-10

Biliary or Digestive Protection by Room Air Interposition for Thermal Ablation of Central Hepatic Tumors

Centre Hospitalier Universitaire de Nice

Completed
61 enrolled
Gastrointestinal

Carcinoma, Liver Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡